Volume 19, Number 4 (January 2013)                   J Birjand Univ Med Sci. 2013, 19(4): 347-354 | Back to browse issues page


XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Erahimzadeh A, Sharifzadeh G, Azarkar Z, Hosseini S, Tohidi Zadeh T, Namaei M H. Comparison of Azithromycin and Ciprofloxacin in treating adults' acute non amebiasis dysenter. J Birjand Univ Med Sci.. 2013; 19 (4) :347-354
URL: http://journal.bums.ac.ir/article-1-1080-en.html

1- Assistant Professor of Infectious Disease, Hepatitis Research Center member, Birjand University of medical science, Birjand, Iran
2- Instructor Social determinants of Health Research Center member, Department of health, Birjand University of medical science, Birjand, Iran
3- Associate Professor of Infectious Disease, Hepatitis Research Center member, Birjand University of medical science, Birjand, Iran.
4- Medical Student, Member of Student Research Committee, Birjand University of medical science, Birjand, Iran
5- Assistant Professor of Microbiology, Hepatitis Research Center member, Birjand University of medical science, Birjand, Iran , mhnamaei@hotmail.com
Abstract:   (10870 Views)
Background and Aim: Invasive diarrhea is a self-limited disease but its antibiotic treatment not only reduces the disease marking time, but also excretion of the microbes and, consequently, a decrease in the pathogenicity of the disease. The present study was conducted to compare patients' resistance to ciprofloxacin and to azithromycin in non-amoebic acute dysenteric. Materials and Methods: In this clinical- trial study 84 patients suffering from non-amoebic dysentery were selected through successive sampling, and were randomly divided into two groups. One group was administered Ciprofloxacin 500mg every 12 hours, the other group Azitromycin 250mg daily (every 24 hours). Then patients examined after 48 hours to see the probable improvement of their previous clinical symptoms. Besides, their first day feces culture was assessed. The obtained data was fed into SPSS software (V: 1/3), and then it was analysed using X2 statistical test at the significant level α=0.05.for afebrility and decreased diarrhea .data analyzed in using test. Results: Out of 84 patients, shigella was diagnosed in 41 (48.8%), 18 patients of whom (43.9%) had been treated with azitromycin and 23 cases (56.1%) had received ciprofloxacin .In 14 samples (16.7%) other microbes had grown (e.g. Salmonella, Campylobacter jejuni, Escherichia Coli). Antibiogram of 55 patients showed that 32 (58.2%) of them were sensitive to ciprofloxacin and 41 subjects (74.5%) to azitromycin .On the third day of treatment the clinical response of the patients was assessed through their probable fever and diarrhea .It was found that 29 cases (93.5%) in azitromycin group and 31 patients (88.5%) in ciprofloxacin group were a febrile. Thus, no significant difference between the two groups was observed (P=0.6). Conclusion: The present study proved that Azitromycin and Ciprofloxacin have the same efficacy in treating non-amoebic dysentery
Full-Text [PDF 190 kb]   (2037 Downloads)    
Type of Study: Original Article | Subject: Infectious disease
Received: 2012/04/17 | Accepted: 2013/04/22 | Published: 2016/03/10

Add your comments about this article : Your username or email:
Write the security code in the box

Send email to the article author


© 2015 All Rights Reserved | Journal of Birjand University of Medical Sciences

Designed & Developed by : Yektaweb